5.20
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt SLDB?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Schlusskurs vom Vortag:
              $5.39
            Offen:
              $5.35
            24-Stunden-Volumen:
                1.73M
            Relative Volume:
              1.68
            Marktkapitalisierung:
                $404.92M
            Einnahmen:
              $14.79M
            Nettoeinkommen (Verlust:
              $-102.44M
            KGV:
              -1.7105
            EPS:
                -3.04
            Netto-Cashflow:
                $-91.73M
            1W Leistung:
              -11.86%
            1M Leistung:
              -11.86%
            6M Leistung:
                +20.65%
            1J Leistung:
              -9.57%
            Solid Biosciences Inc Stock (SLDB) Company Profile
Firmenname
                  
                      Solid Biosciences Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-337-4680
                    
                Adresse
                  
                      500 RUTHERFORD AVENUE, CHARLESTOWN, MA
                    
                Vergleichen Sie SLDB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SLDB
                            
                             
                        Solid Biosciences Inc 
                           | 
                    5.20 | 419.71M | 14.79M | -102.44M | -91.73M | -3.04 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-26 | Eingeleitet | Citigroup | Buy | 
| 2025-01-08 | Eingeleitet | Truist | Buy | 
| 2024-12-13 | Eingeleitet | Wedbush | Outperform | 
| 2024-12-10 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2024-07-15 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2024-06-24 | Hochstufung | Leerink Partners | Market Perform → Outperform | 
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight | 
| 2024-03-28 | Eingeleitet | William Blair | Outperform | 
| 2024-03-15 | Eingeleitet | Citigroup | Buy | 
| 2024-03-14 | Hochstufung | Piper Sandler | Neutral → Overweight | 
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy | 
| 2021-07-12 | Eingeleitet | Piper Sandler | Neutral | 
| 2021-05-27 | Eingeleitet | Jefferies | Buy | 
| 2021-03-16 | Hochstufung | SVB Leerink | Mkt Perform → Outperform | 
| 2021-03-09 | Eingeleitet | Barclays | Overweight | 
| 2021-01-08 | Hochstufung | Credit Suisse | Underperform → Neutral | 
| 2020-07-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2020-05-07 | Herabstufung | Evercore ISI | Outperform → In-line | 
| 2019-10-11 | Eingeleitet | Evercore ISI | Outperform | 
| 2019-08-29 | Herabstufung | Citigroup | Neutral → Sell | 
| 2019-08-19 | Hochstufung | SVB Leerink | Mkt Perform → Outperform | 
| 2019-08-16 | Hochstufung | Chardan Capital Markets | Neutral → Buy | 
| 2019-05-14 | Herabstufung | Credit Suisse | Neutral → Underperform | 
| 2019-05-14 | Herabstufung | Goldman | Neutral → Sell | 
| 2019-02-08 | Hochstufung | Citigroup | Sell → Neutral | 
| 2019-02-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2018-11-06 | Eingeleitet | Citigroup | Sell | 
| 2018-09-06 | Eingeleitet | Credit Suisse | Neutral | 
                    Alle ansehen
                    
                  
                Solid Biosciences Inc Aktie (SLDB) Neueste Nachrichten
Published on: 2025-11-04 02:33:46 - newser.com
Is Solid Biosciences Inc. stock positioned for long term growthJuly 2025 Patterns & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-11-03 21:39:09 - newser.com
Can Solid Biosciences Inc. stock beat analyst upgradesJuly 2025 Setups & Verified Swing Trading Watchlists - newser.com
Solid Biosciences (SLDB) Reports Promising Interim Data on Duche - GuruFocus
Solid Biosciences Reports Third Quarter 2025 Financial - GlobeNewswire
Does Solid Biosciences Inc. stock trade at a discount to peersDip Buying & Stock Portfolio Risk Management - newser.com
What’s next for Solid Biosciences Inc. stock price2025 Top Gainers & Community Verified Trade Signals - newser.com
Strategies to average down on Solid Biosciences Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com
Is Solid Biosciences Inc. stock in correction or buying zoneJuly 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
How to monitor Solid Biosciences Inc. with trend dashboardsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
Will Solid Biosciences Inc. stock reach all time highs in 2025Oil Prices & Capital Efficient Trading Techniques - newser.com
What insider trading reveals about Solid Biosciences Inc. stockJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
What momentum indicators show for Solid Biosciences Inc. stock2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Why Solid Biosciences Inc. stock is trending among retail tradersJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
Using flow based indicators on Solid Biosciences Inc.2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Using Bollinger Bands to evaluate Solid Biosciences Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
Predicting Solid Biosciences Inc. trend using moving averagesJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
Solid Biosciences Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
How sustainable is Solid Biosciences Inc. stock dividend payoutWeekly Profit Analysis & Reliable Volume Spike Alerts - newser.com
Applying sector rotation models to Solid Biosciences Inc.Portfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
Solid Biosciences to Participate at Upcoming Investor Conferences - The Manila Times
Solid Biosciences (SLDB) Projected to Post Earnings on Wednesday - MarketBeat
Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):